LDC has exited its investment in PAM Healthcare Limited, a provider of occupational health and wellbeing services, through a £100 million transaction with Optima Health PLC, positioning PAM for future growth in the evolving UK preventative healthcare market.
Information on the target
PAM Healthcare Limited (“PAM”) is a prominent player in the preventative healthcare sector, specializing in occupational health and wellbeing services. Established to cater to both corporate and public sector clients, PAM has built a robust reputation for delivering comprehensive health solutions. The company is headquartered in Warrington and has been supported by LDC since 2021, during which time it has expanded its service offerings and client base.
With a dedicated workforce of over 450 employees and a network of associate clinicians, PAM provides a wide range of services, including health surveillance, absence management, physiotherapy, employee assistance programs, and specialist assessments. This diverse portfolio positions PAM as a trusted partner for blue-chip organizations seeking to enhance employee health and productivity.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry overview in the target’s specific country
The UK healthcare industry is undergoing significant transformation, driven by an increasing focus on preventative care and employee wellbeing. As organizations recognize the impact of health on productivity, there is a
Similar Deals
Bridgepoint Advisers Limited → mydentist
2025
Sycamore Partners → Walgreens Boots Alliance’s UK-based pharmacy chain
2025
Optima Health PLC
invested in
PAM Healthcare Limited
in 2023
in a Buyout deal
Disclosed details
Transaction Size: $123M
Enterprise Value: $123M
Equity Value: $123M